Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis
出版年份 2020 全文链接
标题
Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis
作者
关键词
-
出版物
Science Immunology
Volume 5, Issue 52, Pages eaba0759
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2020-10-03
DOI
10.1126/sciimmunol.aba0759
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Defining the emergence of myeloid-derived suppressor cells in breast cancer using single-cell transcriptomics
- (2020) Hamad Alshetaiwi et al. Science Immunology
- Cross‐talk between tumors at anatomically distinct sites
- (2020) Amanda J. Oliver et al. FEBS Journal
- DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25
- (2020) Linbin Yang et al. NATURE
- Predictive factors for hyperprogressive disease during nivolumab as anti-PD1 treatment in patients with advanced gastric cancer
- (2019) Akinori Sasaki et al. Gastric Cancer
- Regulatory T cells mediate specific suppression by depleting peptide–MHC class II from dendritic cells
- (2019) Billur Akkaya et al. NATURE IMMUNOLOGY
- PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
- (2019) Takahiro Kamada et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comprehensive Integration of Single-Cell Data
- (2019) Tim Stuart et al. CELL
- Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicines
- (2019) Channakeshava Sokke Umeshappa et al. Nature Communications
- Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non–Small Cell Lung Cancer Treated With Nivolumab
- (2019) Suzanne L. Topalian et al. JAMA Oncology
- CTLA-4–mediated transendocytosis of costimulatory molecules primarily targets migratory dendritic cells
- (2019) Vitalijs Ovcinnikovs et al. Science Immunology
- Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy
- (2019) Mehmet Asim Bilen et al. BMC CANCER
- Site‐specific response patterns, pseudoprogression, and acquired resistance in patients with melanoma treated with ipilimumab combined with anti–PD‐1 therapy
- (2019) Ines Pires da Silva et al. CANCER
- Liver-Mediated Adaptive Immune Tolerance
- (2019) Meijuan Zheng et al. Frontiers in Immunology
- Non-conventional Inhibitory CD4 + Foxp3 − PD-1 hi T Cells as a Biomarker of Immune Checkpoint Blockade Activity
- (2018) Roberta Zappasodi et al. CANCER CELL
- Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients With Melanoma Treated With Pembrolizumab
- (2018) Richard W. Joseph et al. CLINICAL CANCER RESEARCH
- Targets for immunotherapy of liver cancer
- (2018) Tim F. Greten et al. JOURNAL OF HEPATOLOGY
- Integrating single-cell transcriptomic data across different conditions, technologies, and species
- (2018) Andrew Butler et al. NATURE BIOTECHNOLOGY
- A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments
- (2018) Kevin C. Barry et al. NATURE MEDICINE
- Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells
- (2018) Chi Ma et al. SCIENCE
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity
- (2018) David Wang et al. Cell Reports
- Organ-specific response to nivolumab in patients with non-small cell lung cancer (NSCLC)
- (2018) Sabine Schmid et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Modulation of EZH2 expression in T cells improves efficacy of anti–CTLA-4 therapy
- (2018) Sangeeta Goswami et al. JOURNAL OF CLINICAL INVESTIGATION
- High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy
- (2018) Matthew M. Gubin et al. CELL
- Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity
- (2018) Kelsey E. Sivick et al. Cell Reports
- T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
- (2017) Alexander C. Huang et al. NATURE
- Is autoimmunity the Achilles' heel of cancer immunotherapy?
- (2017) Carl H June et al. NATURE MEDICINE
- Glucocorticoid receptor in T cells mediates protection from autoimmunity in pregnancy
- (2017) Jan Broder Engler et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC
- (2017) Paul C. Tumeh et al. Cancer Immunology Research
- Regulatory T cells in cancer immunotherapy
- (2016) Atsushi Tanaka et al. CELL RESEARCH
- Presentation of hepatocellular antigens
- (2016) Arash Grakoui et al. Cellular & Molecular Immunology
- Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells
- (2016) Andrea Kristina Horst et al. Cellular & Molecular Immunology
- Immunity, tolerance and autoimmunity in the liver: A comprehensive review
- (2016) Derek G. Doherty JOURNAL OF AUTOIMMUNITY
- Tumor immune profiling predicts response to anti–PD-1 therapy in human melanoma
- (2016) Adil I. Daud et al. JOURNAL OF CLINICAL INVESTIGATION
- Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer
- (2016) Susan Halabi et al. JOURNAL OF CLINICAL ONCOLOGY
- Regulatory T cells, especially ICOS+ FOXP3+ regulatory T cells, are increased in the hepatocellular carcinoma microenvironment and predict reduced survival
- (2016) Jian-Fei Tu et al. Scientific Reports
- Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery
- (2016) Suzanne I.S. Mosely et al. Cancer Immunology Research
- Interleukin-5 Facilitates Lung Metastasis by Modulating the Immune Microenvironment
- (2015) R. Zaynagetdinov et al. CANCER RESEARCH
- Nanoparticle-based autoantigen delivery to Treg-inducing liver sinusoidal endothelial cells enables control of autoimmunity in mice
- (2015) Antonella Carambia et al. JOURNAL OF HEPATOLOGY
- Hepatocytes as Immunological Agents
- (2015) Ian N. Crispe JOURNAL OF IMMUNOLOGY
- Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells
- (2015) A. R. Sanchez-Paulete et al. Cancer Discovery
- Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner
- (2015) Rikke B. Holmgaard et al. Cell Reports
- The landscape of metastatic progression patterns across major human cancers
- (2015) Jan Budczies et al. Oncotarget
- Depletion of myeloid-derived suppressor cells during interleukin-12 immunogene therapy does not confer a survival advantage in experimental malignant glioma
- (2014) B Thaci et al. CANCER GENE THERAPY
- Immune tolerance in liver disease
- (2014) Ian N. Crispe HEPATOLOGY
- Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy
- (2014) Xiaozhou Fan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CD83 Expression in CD4 + T Cells Modulates Inflammation and Autoimmunity
- (2014) Simone Reinwald et al. JOURNAL OF IMMUNOLOGY
- GILZ Promotes Production of Peripherally Induced Treg Cells and Mediates the Crosstalk between Glucocorticoids and TGF-β Signaling
- (2014) Oxana Bereshchenko et al. Cell Reports
- Higher Frequencies of GARP+CTLA-4+Foxp3+ T Regulatory Cells and Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Are Associated with Impaired T-Cell Functionality
- (2013) S. Kalathil et al. CANCER RESEARCH
- Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
- (2013) Tyler R. Simpson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells
- (2013) M. J. Selby et al. Cancer Immunology Research
- CD4+CD25+ regulatory T cells control CD8+ T-cell effector differentiation by modulating IL-2 homeostasis
- (2011) A. McNally et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells
- (2010) Marc Vocanson et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Macrophage-dependent nitric oxide expression regulates tumor cell detachment and metastasis after IL-2/anti-CD40 immunotherapy
- (2010) Jonathan M. Weiss et al. JOURNAL OF EXPERIMENTAL MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search